Background As current therapies for canine osteoarthritis (OA) provide mainly symptomatic
improvement and fail to address the complex pathology of the disease, mesenchymal stem …

Osteoarthritis (OA) is a chronic joint disease afflicting a substantial portion of the world's
population with no currently available cure. Mesenchymal stem cell (MSC)-based therapies …

Osteoarthritis (OA) is currently an incurable and progressive condition in dogs causing
chronic joint pain and possibly increasing disability. Due to the poor healing capacity of …

Conventional treatments of osteoarthritis (OA) reduce pain and the inflammatory response
but do not repair the damaged cartilage. Xenogeneic peripheral blood‐derived equine …

Osteoarthritis is a frequently occurring joint disorder in veterinary practice. Current
treatments are focused on pain and inflammation; however, these are not able to reverse the …

Background Rheumatoid arthritis (RA) is a debilitating and painful disease leading to
increased morbidity and mortality and novel therapeutic approaches are needed. The …

Background Recently, cell-based tissue engineering approaches using mesenchymal stem
cells (MSCs) have been used to treat osteoarthritis (OA). However, the efficacy of human …

Background This study aimed at assessing the effectiveness and safety of repeated
administrations of allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) …

Osteoarthritis (OA) is a highly prevalent condition in dogs, causing a substantial reduction in
quality of life and welfare of the animals. Current disease management focusses on pain …

Osteoarthritis is a progressive degenerative disease affecting joints. It is associated with
structural and functional changes that cause lameness and pain in dogs. Mesenchymal stem …